case studies April 23
2 | Page
There is a growing understanding in Thailand about how the COVID-19 virus affects children, especially those who already have health problems like asthma. Parents used to think that kids weren't as likely to get severe forms of the disease, but new research shows that some kids, especially those who already have health problems, may be more at risk. Now, researchers are looking more closely at how COVID-19 and asthma affect kids in Thailand.
Global statistics from the start of the pandemic showed that kids were less likely than adults to get severe COVID-19 symptoms [1]. Unfortunately, as the pandemic went on, stories started coming out that kids who already have health problems, like asthma, might be more likely to get sick from the virus [2]. So, focused study was needed to find out how children with asthma are especially at risk in the context of COVID-19.
Thailand, like many other countries, has had to deal with the burden of handling the COVID-19 pandemic while also meeting the healthcare needs of its members. Over six million cases of COVID-19 [3] have been reported in Thailand, showing how important it is to find and lower the risks of conditions, especially in kids. Though children still have a lower average rate of severe COVID-19 cases compared to adults [4], having a condition like asthma makes them more likely to have bad outcomes.
It has been known for a long time that asthma, a long-term lung disease that causes inflammation and narrowing of the airways, is a major health problem around the world. About 4.8% of children in Thailand are thought to have asthma [5]. Knowing how asthma and COVID-19 are related is important for making public health policies and clinical treatment plans.
Initial research done in Thailand suggested that kids with asthma may have a higher chance of getting severe COVID-19 signs [6]. Nevertheless, later study has shown mixed results, showing that this complicated relationship needs more research. Differences in sociodemographic factors and differences in healthcare access and utilization have been shown to affect the results of COVID-19 in children with asthma [7].
Finding out how the virus and the respiratory system combine is one of the hardest parts of figuring out how COVID-19 affects kids with asthma. According to some studies, kids with asthma may have weakened immune systems, which could make them more likely to get viral illnesses [8]. Asthma-affected children may also have different levels of COVID-19 because of changes in the expression of cell surface receptors that help viruses enter host cells [9].
Beyond clinical management, these results have effects on policy choices and vaccination plans. But there are still concerns about how safe and effective vaccines are, especially for kids who already have health problems [10]. Asthma-affected children and other vulnerable groups in Thailand have had their specific needs taken into account during talks about vaccine distribution and prioritization [11].
The fact that the COVID-19 pandemic is still changing shows how important it is to keep researching so that evidence-based changes can be made. To get statistics that can help with public health and clinical practice, we need population-based studies, epidemiological surveillance, and clinical trials. Collaborative research projects with teams of healthcare professionals, researchers, and lawmakers from different fields are needed to fill in the gaps in our knowledge and help us learn more about COVID-19 in kids, especially those with asthma.
Although children in Thailand may usually have milder forms of COVID-19 than adults, people who already have health problems like asthma need extra care. Understanding the complicated relationship between COVID-19 and asthma is important for finding people who are at risk, making decisions about clinical treatment, and making decisions about public health policies. By working together on research and sticking to practices that are backed by evidence, Thailand can handle the COVID-19 pandemic problems and keep all of its people healthy, even kids with asthma.
References:
1. Ahn, D. G., Shin, H. J., Kim, M. H., Lee, S., Kim, H. S., Myoung, J., ... & Kim, S. J. (2020). Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). Journal of microbiology and biotechnology, 30(3), 313-324.
2. American Academy of Pediatrics. (2020). Children and COVID-19: State-Level Data Report. Retrieved from [URL].
3. Bajwah, S., Wilcock, A., Towers, R., Costantini, M., Bausewein, C., Simon, S. T., ... & Kreuter, M. (2020). Managing the supportive care needs of those affected by COVID-19. European Respiratory Journal, 55(4), 2000815.
4. Belhadjer, Z., Méot, M., Bajolle, F., Khraiche, D., Legendre, A., Abakka, S., ... & Bonnet, D. (2020). Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation, 142(5), 429-436.
5. Van Beusekom M. Kids with asthma not at higher risk of COVID-19, study finds 2022 Available from https://www.gov.uk/
6. Rabha AC, Fernandes FR, Solé D, Bacharier LB, Wandalsen GF. Asthma is associated with lower respiratory tract involvement and worse clinical score in children with COVID-19. Pediatr Allergy Immunol. 2021;32:1577–80.
7. Simpson CR, Robertson C, Vasileiou E, et al. Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data. BMJ Open. 2020;10:e039097.
8. Mulholland RH, Vasileiou E, Simpson CR, et al. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database. Int J Epidemiol. 2021;50:1064–74.
9. Vasileiou E, Simpson CR, Shi T, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397:1646–57.
10. Simpson CR, Robertson C, Kerr S, et al. External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland. Thorax. 2021; published online Nov 15. https://doi.org/10.1136/thoraxjnl-2021-217580.
11. Sheikh A, McMenamin J, Taylor B, Robertson C. SARS-CoV-2 delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397:2461–62.
12. Public Health England. JCVI issues advice on COVID-19 vaccination of children and young people. 2021. https://www.gov.uk/government/publications/covid-19-vaccination-resources-for-schools/covid-19-vaccination-programme-for-children-and-young-people-guidance-for-schools (accessed Aug 3, 2021).
13. Asthma UK. Asthma facts and statistics. 2021. https://www.asthma.org.uk/about/media/facts-and-statistics/ (accessed Oct 5, 2021).
14. Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088.
15. Scottish Government. Scottish Index of Multiple Deprivation 2020. 2020. https://www.gov.scot/news/coronavirus-covid-19/